Jennifer Sutton provides an overview of safety considerations for next-generation androgen receptor inhibitors for non-metastatic castration-resistant prostate cancer and the role of the nurse.
Brenda Martone provides a summary of how a GU nurse can provide crucial support to patients during treatment sequencing decisions for metastatic castration-resistant prostate cancer (mCRPC).
GU NURSES CONNECT has summarised the oncology nursing highlights from ESMO 2021 and the European Oncology Nursing Society (EONS14).
Joanne Chien provides an overview of practical considerations when sequencing treatments for mCRPC patients in clinical practice and how recent real-world data can help guide these decisions.
Janet Forgenie provides an overview of how COVID-19 has impacted prostate cancer care and side effect management.
GU NURSES CONNECT has summarised the highlights from ASCO 2020 for you.
GU CONNECT expert, Prof. Sandy Srinivas discusses maintenance therapy for metastatic urothelial cancer, and in particular the practice-changing clinical trial JAVELIN 100.
Episode 1: An introduction
Prof. Steven Joniau provides an overview of nmCRPC and highlights of the SPARTAN, PROSPER and ARAMIS trials including the recent overall survival update and discusses the safety and quality of life data.
Our GU CONNECT experts provide their thoughts and opinions on the challenging topic of the role and place of genetic testing in prostate cancer.
GU CONNECT has produced an interactive e-learning, slide set and video about current opinions on managing nmCRPC and the implications of new imaging modalities.
Dr Ray Manneh Kopp takes a look at the highlights of 2020 from GU CONNECT.
Episode 2: mCSPC Plenary Session 1
Episode 3: mCSPC Plenary Session 2
Episode 3: Kidney Cancer
Episode 2: Urothelial Cancer
GU CONNECT expert, Prof. Gert De Meerleer provides his perspective on the management of oligometastatic prostate cancer.
GU CONNECT expert, Dr Fabio Schutz provides his perspective on optimising patient selection and treatment options for metastatic castration-sensitive prostate cancer.
GU cancer update by Dr. Elena Castro, Hospital Universitario Virgen de la Victoria, Málaga, Spain.
Dr. Neal Shore provides his perspective on treatment sequence for mCRPC after intensified therapy in mCSPC.
Episode 1 focuses on radium-223 and guest speaker Dr Neal Shore joins the discussion.
Episode 2 focuses on PSMA-targeted radiopharmaceuticals.
GU NURSES CONNECT ha resumido los aspectos más destacados de la enfermería oncológica de la ESMO 2021 y la Sociedad Europea de Enfermería Oncológica (EONS14).
Dr. Ray Manneh Kopp discusses treatment strategies for non-metastatic castration-resistant prostate cancer (nmCRPC) and how to individualise them to the patient.
This comprehensive resource looks at PARP inhibition and DDR as therapeutic targets across multiple tumour types
Prof. Thomas Powles and GU CONNECT expert, Assoc. Prof. Georg Hutterer discuss the role of VEGFR-TKIs in the treatment of advanced renal cell carcinoma (RCC) alone or in combination with immunotherapy.
GU CONNECT expert, Dr. Alicia Morgans provides her perspective on how to integrate patient preference into treatment decisions for advanced prostate cancer.
Prof. David Pfister takes a look at the highlights of 2021 from GU CONNECT, in particular, the new trials and practice-changing developments in prostate, urothelial and kidney cancer.
GU CONNECT has developed a comprehensive resource which is available on ESMO OncologyPRO, providing information on PARP inhibitors in prostate cancer
En el segundo episodio de esta serie de podcasts, Pablo Peinado y la Dra. Elena Castro analizan los inhibidores de PARP, cómo funcionan, revisan datos clave de ensayos, cómo seleccionar PARPi y dónde encajan en la secuencia general de tratamiento.
On-demand educational resources (e-learning, video and slide set) are now available following a successful GU CONNECT Experts Knowledge Share event on the topic of targeting advanced prostate cancer with PARP inhibitors: Who, When and How?
Prof. Neeraj Agarwal takes a look at poly-ADP ribose polymerase inhibitors (PARPi's) in prostate cancer and in particular the latest clinical developments.
Brenda Martone, Nurse Practitioner is joined by Assoc. Prof. Alicia Morgans from GU CONNECT to discuss shared decision-making in non-metastatic castration-resistant prostate cancer (nmCRPC) and the treatment considerations to maintain quality of life.
In this podcast Assoc. Prof. Tanya Dorff and Dr Neal Shore focus on patients with metastatic castration-sensitive prostate cancer (mCSPC) and discuss when to use androgen receptor signalling inhibitors (ARSI) and taxanes for these patients.
Prostate Cancer Update from ASCO GU, ASCO and EAUN 2022
We celebrate our 10-year anniversary at the COR2ED booth during ESMO 2022. In 10 years, 500,000 healthcare professionals have trusted our educational programmes.
COR2ED brings you an update on a selection of late-breaking abstracts presented in the Presidential Symposia at ESMO 2022.
Pablo Peinado, Research Nurse Coordinator, reviews key abstracts from EONS15 at ESMO 2022.
GU NURSES CONNECT ha resumido los aspectos más destacados de la enfermería oncológica de la ESMO 2022 y la Sociedad Europea de Enfermería Oncológica (EONS15).
On-demand e-learning, video replay and slide set now available
On-demand video and slides now available
Educational podcast now available
Module 1 - PARP inhibitors in advanced prostate cancer
The physicians' perspective
Episode 1: Clinical implementation of PARPi monotherapy for prostate cancer patients – a US and EU perspective
The role of the nurse in nmCRPC patient management
A podcast from GU oncology experts
Episode 1: Non-Small-Cell Lung Cancer Update: ADAURA trial
Listen as GU oncology nurses share their views in this clinical update podcast
Prof. Thomas Powles shares his perspective on key RCC data
A clinical update for oncology nurses
Episode 1: Clinical implementation of testing and PARPi monotherapy
Journey through an interactive patient case
How will the latest data impact clinical practice?
Moderated by the Oncology Brothers. Episode 1 of a 3-part video podcast series